Receptor p75 is a classical membrane receptor, which consists of an extracellular region, a trans membrane region, and an intracellular C terminus death domain. p75 is involved in the activation of neu rotrophic factors and plays an essential role in the regulation of cell functions such as proliferation, differen tiation, synaptogenesis, neuronal plasticity, and survival or apoptosis. It is supposed that p75 accelerates the positive effects of neurotrophins being a part of the complex with the Trk receptor; however, in the absence of Trk receptors, the interaction between p75 and neurotrophins leads to cell apoptosis. The interest in the p75 receptor has increased dramatically in the past few years, as it has been shown that p75 may play a crucial role in the genesis of neurodegenerative disorders, in particular, Alzheimer's disease. The interaction between p75 and β amyloid leads to neuronal death in the brain. Identification of the p75 regions involved in the develop ment of pathology is of great importance for understanding the mechanisms of Alzheimer's disease and for creating targeted therapeutic agents for this disorder. In the present work, immunological approaches have been used for structure function mapping of the extracellular domain of the p75 receptor during the devel opment of a neurodegenerative process in olfactory bulbectomized animals. The nine extracellular regions selected on the basis of X ray structure analysis of p75 molecule hypothetically could include β amyloid binding sites and participate in the progression of pathology. Peptides with the amino acid sequences analo gous to the selected regions were synthesized. Immunization with such fragments conjugated with hemocy anin induced the formation of antipeptide antibodies in experimental animals. However, only immunization with fragment (167-176) prevented the memory loss and neuronal death in the cortex and hippocampus of bulbectomized mice. This fragment had no effect on sham operated mice. The results indicate that fragment (167-176) of the p75 sequence deserves further research as a potential basis of the targeted immunotherapy of Alzheimer's disease.